Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-aminooctadecane-1,3-diol
2. Dihydrosphingosine
3. Erythro-d-sphinganine
4. Safingol
5. Safingol Hydrochloride
6. Safingol, ((r*,s*)-(+-))-isomer
7. Safingol, (r-(r*,r*))-isomer
8. Safingol, (s-(r*,s*))-isomer
9. Saginfol
10. Spc 100270
11. Spc-100270
12. Sphinganine
13. Threo-dihydrosphingosine
1. Dl-threo-dihydrosphingosine
2. 2304-75-8
3. 6036-86-8
4. Dihydrosphingosine
5. Dl-threo Dihydrosphingosine
6. D-threo-dihydrosphingosine
7. 73938-69-9
8. 3102-56-5
9. Dl-erythro-1,3-dihydroxy-2-aminooctadecane
10. Schembl3509781
11. Zinc8216386
12. Hsci1_000011
13. Akos024458630
14. Spc-100580
15. J-009299
Molecular Weight | 301.5 g/mol |
---|---|
Molecular Formula | C18H39NO2 |
XLogP3 | 5.8 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 16 |
Exact Mass | 301.298079487 g/mol |
Monoisotopic Mass | 301.298079487 g/mol |
Topological Polar Surface Area | 66.5 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 200 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?